The authors profiled EVs from nine murine and human cell lines (melanoma, carcinoma, melanocyte, HEK293T) using 2D culture, SEC enrichment (70 nm resin), ultracentrifugation, and UHPLC-MS/MS on an Orbitrap Exploris 240, detecting >500 lipid species across major classes (Cer, PC, PE, PS, SM, ST, TG, FA) with 4 biological replicates per line . Proteomic QC by SP3/LC-MS/MS identified a 52-protein core set including CD9 and MFGE8, supporting EV enrichment .
Strengths: quantitative surrogate calibration (UltimateSPLASH ONE), multi-class coverage, randomized injection order with QC samples, and orthogonal proteomic validation. Limitations: only nine 2D-culture lines; SEC may co-enrich non-vesicular lipid carriers, a known confounder in EV lipidomics ; no in vivo validation of the nSMase2-ceramide biogenesis hypothesis; lipid data availability still pending public release. This resource enables disease-focused EV lipidomics comparisons such as those in Parkinson's disease .
Falsification criterion: independent replication with broader tissue panels failing to reproduce lineage signatures would challenge generalizability.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.